Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
160M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
60M
-
Shares change
-
+7.54M
-
Total reported value, excl. options
-
$416M
-
Value change
-
+$24.3M
-
Put/Call ratio
-
1.22
-
Number of buys
-
97
-
Number of sells
-
-97
-
Price
-
$6.93
Significant Holders of NOVAVAX INC - Common Stock (NVAX) as of Q1 2023
303 filings reported holding NVAX - NOVAVAX INC - Common Stock as of Q1 2023.
NOVAVAX INC - Common Stock (NVAX) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60M shares
of 160M outstanding shares and own 37.48% of the company stock.
Largest 10 shareholders include STATE STREET CORP (11.1M shares), VANGUARD GROUP INC (10.2M shares), BlackRock Inc. (4.77M shares), SHAH CAPITAL MANAGEMENT (4.25M shares), RENAISSANCE TECHNOLOGIES LLC (3.54M shares), BANK OF AMERICA CORP /DE/ (2.49M shares), MORGAN STANLEY (2.45M shares), COATUE MANAGEMENT LLC (1.77M shares), CITIGROUP INC (1.7M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.25M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.